Watch live: RFK Jr. testifies at Senate confirmation hearing for HHS secretary

Watch live: RFK Jr. testifies at Senate confirmation hearing for HHS secretary


[The stream is slated to start at 10 a.m. ET. Please refresh the page if you do not see a player above at that time.]

Robert F. Kennedy, President Donald Trump’s controversial pick to lead the Department of Health and Human Services, is testifying on Wednesday before a Senate panel that is crucial to advance his nomination.

Kennedy is testifying first before the Senate Committee on Finance, which will ultimately vote on whether his nomination as HHS Secretary advances to the full chamber. In the Republican-controlled Senate, Kennedy can only lose three GOP votes if all Democrats oppose him.

He will also appear before the Senate Committee on Health, Education, Labor and Pensions, or HELP, for a courtesy hearing on Thursday. If confirmed, Kennedy will take the reins of a $1.7 trillion agency that oversees vaccines and other medicines, scientific research, public health infrastructure, pandemic preparedness, food and tobacco products and government-funded health care for millions of Americans.

The heads of the Food and Drug Administration, Centers for Disease Control and Prevention, National Institutes of Health and Centers for Medicare & Medicaid Services, among other federal health agencies, all report to the HHS secretary.

Kennedy, 71, is one of Trump’s more controversial Cabinet nominees, facing criticism from both sides of the aisle. He is a prominent vaccine skeptic, making false claims that they are linked to autism despite decades of studies that debunk that association.

Some critics have even argued that his work advocating against vaccine use has cost lives, and could deter more Americans from getting recommended shots at a time when vaccination rates are declining.

But Kennedy, in his opening remarks before the panel, pushed back on claims that he is anti-vaccine or anti-industry.

“I am neither; I am pro-safety,” Kennedy said. “I worked for years to raise awareness about the mercury and toxic chemicals in fish, but that didn’t make me anti-fish. All of my kids are vaccinated, and I believe vaccines have a critical role in healthcare.”

A protester in the hearing room shouted when Kennedy denied he was anti-vaccine, accusing him of lying. It sparked applause, briefly interrupting his opening remarks.

Kennedy is also the founder of the nonprofit Children’s Health Defense, the most well-funded anti-vaccine organization in the U.S. In a government ethics agreement last week, Kennedy said he stopped serving as chairman or chief legal counsel for the organization as of December.

In a likely preview of the Senate Finance Committee hearing, Sen. Elizabeth Warren, D-Mass., last week issued a letter pressing Kennedy to answer 175 questions on topics such as vaccines, the Affordable Care Act, drug pricing, his changing views on reproductive rights and his suggestion to fire FDA and NIH workers, among others.

This week’s hearings will also provide a glimpse of how Kennedy plans to pursue his broad, so-called Make America Healthy Again platform if confirmed as the nation’s top health official. The platform argues that a corrupt alliance of drug and food companies and the federal health agencies that regulate them are making Americans less healthy. Kennedy has long contended that the agencies that HHS oversees need reform or a sweeping overhaul.

Kennedy’s supporters say some of his stances around food, such as highlighting the risks of food additives and ultra-processed products, have hit on broad appeal among Republicans and some Democrats.

But Kennedy on Wednesday said he is not “the enemy of food producers,” noting that American farms are “the bedrock of our culture and national security.”

Caroline Kennedy, RFK Jr.’s cousin and daughter of former President Kennedy, wrote a letter to senators on Tuesday that referred to her cousin as a “predator” and urged them not to confirm him. 



Source

JPMorgan’s top biotech and pharma picks for the second half
Health

JPMorgan’s top biotech and pharma picks for the second half

Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. […]

Read More
How twin sister triathletes doubled down on sports success to raise health-startup millions from investors
Health

How twin sister triathletes doubled down on sports success to raise health-startup millions from investors

During their last year of completing work for doctoral degrees in physiology, twin sisters Michal Mor and Merav Mor started to compete in Ironman triathlon races. The demand for peak fitness led them to the realize the importance of understanding personal metabolism, and the lack of data being collected on it through devices accessible to […]

Read More
It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech
Health

It’s not just AI — China’s quickly gaining an edge over the U.S. in biotech

Two graduate students research chemical products in a laboratory in Xiwangzhuang Town, Zaozhuang City, Shandong province of China, on Dec. 26, 2023. Nurphoto | Nurphoto | Getty Images BEIJING — For all the attention on U.S.-China competition in artificial intelligence, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development. […]

Read More